http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110551201-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-412
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-51
filingDate 2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110551201-B
titleOfInvention A novel cyclic peptide derived from bone morphogenetic protein 2, preparation method and application thereof
abstract The invention relates to a novel BMP-2-derived cyclic peptide, a preparation method and an application thereof. The novel BMP-2-derived cyclic peptide is selected from one of the following cyclized polypeptides: the sequence is: 1. CKIPKASSVPTELSAISMLYLGPGGDWIVAC; 2. It has 80% homology with the polypeptide defined in 1; the preparation method of the novel bone morphogenetic protein 2-derived cyclic peptide and the application of the novel bone morphogenetic protein 2-derived cyclic peptide in the preparation of a composite material for promoting the repair of large volume bone defects . The beneficial effects of the present invention are as follows: the specially modified BMP2 cyclized polypeptide used in the present invention has the effect of efficiently inducing osteogenesis and can effectively promote the repair of large-volume bone defects; the specially modified BMP2 cyclized polypeptide used in the present invention is of human origin Polypeptide has good biocompatibility and no side effects such as immune rejection; the specially modified BMP2 cyclized polypeptide applied in the present invention can be loaded on various biological materials and has broad application prospects.
priorityDate 2019-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GKR0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9MYV3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15692
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50412
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21895894
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID458090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448212190
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29373
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26617
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ00731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5F4C3S2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83906
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15691
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67965
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49151
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30632
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ804S2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12156
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449517503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23501187
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421109490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6293
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413349964
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ90751
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378779
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0ZCS4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94524
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21274
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12643
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009349
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q2TVI4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67860
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO19006
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID477162
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99PS1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6QDM7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ9P401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547201
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453134186
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID615037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549133
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO46564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862

Total number of triples: 81.